Very interesting article chicagoest. Thanks for posting because it's a valuable read.

The summary sort of underscores a point I've made previously that I sure hope Don has a brilliant backroom working out a business strategy.

From the article -

Parting Thoughts

As a finance professional and enthusiastic hobby biologist who loves to read biology books and take open online medicine courses, I am inclined to close on the following note: I hope that while the scientific work is the most important value driver of a biotech company, there is room for savvy financial experts to add value, such as tasks like conceiving and negotiating partnerships that increase risk-adjusted returns and hence value to all sides. As prominent biotech investor Stephen Diggle noted in a recent Bloomberg article: “Bringing financial expertise to fledgling biotech companies helps create value because management consists mostly of scientists who focus on research and development.” Of course, if the financial expert has some domain expertise and is passionate about the science, all the better!

GLTA

Toinv